中證監:推進民企債券「央地合作增信」常態化工作
上海證券交易所近日組織召開支持民營企業債券融資座談會,充分聽取民營企業對於進一步優化債券融資支持機制、引導金融資源精準支持民營企業發展的意見和建議。吉利集團、東方盛虹、物美集團、山鷹國際、富通集團等九家民營企業在座談會上表示,公司債券市場是民營企業直接融資的重要渠道,有助於企業優化債務結構、拓寬融資渠道及提升資本市場形象。
中證監債券部有關負責人在會上提到,要毫不動搖地支持、服務民營企業債券融資,引導民營企業在創新發展中用好科技創新公司債券、綠色公司債券及REITs等多種特色品種。要深化民營企業債券融資增信支持機制,切實做好民營企業債券「央地合作增信」常態化推進工作,著力提升民營經濟、中小企業發行債券融資的可得性和便利性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.